Abdullah Alattar
Impact in
-
- Tryptophan and brain disorders
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Genomics, phytochemicals, and oxidative stress 5
- Inflammasome and immune disorders 4
-
- Neuroinflammation and Neurodegeneration Mechanisms 5
- Co-authors
- Reem Alshaman (35 shared papers)Fawad Ali Shah (12 shared papers)Shupeng Li (7 shared papers)Mohammed M.H. Al-Gayyar (4 shared papers)Lina T. Al Kury (5 shared papers)Zhen Tan (3 shared papers)Sawsan A. Zaitone (10 shared papers)Tahir Ali (2 shared papers)
- Journals
- Pharmaceuticals (7 papers)Pharmaceutics (3 papers)Redox Report (2 papers)Neurochemical Research (2 papers)Archives of Medical Science (2 papers)
- Partner nations
- Saudi ArabiaEgyptPakistan
In The Last Decade
Abdullah Alattar
30 papers receiving 509 citations
Peers
Comparison fields: 5 of 89
- Biological Psychiatry 23
- Pharmaceutical Science 51
- Neurology 50
- Pharmacology 46
- Nephrology 37
Countries citing papers authored by Abdullah Alattar
This map shows the geographic impact of Abdullah Alattar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Alattar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Alattar more than expected).
Fields of papers citing papers by Abdullah Alattar
This network shows the impact of papers produced by Abdullah Alattar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Alattar. The network helps show where Abdullah Alattar may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdullah Alattar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 43 | |
| 2 | 2022 | 42 | |
| 3 | 2021 | 39 | |
| 4 | 2022 | 33 | |
| 5 | 2020 | 31 | |
| 6 | 2020 | 28 | |
| 7 | 2021 | 27 | |
| 8 | 2024 | 24 | |
| 9 | 2021 | 22 | |
| 10 | 2022 | 21 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 17 | |
| 14 | 2022 | 16 | |
| 15 | 2023 | 15 | |
| 16 | 2020 | 13 | |
| 17 | 2023 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2023 | 11 | |
| 20 | 2023 | 11 |
About Abdullah Alattar
Abdullah Alattar is a scholar working on Molecular Biology, Neurology, Nephrology, Pharmaceutical Science and Oncology, having authored 36 papers that have together received 513 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Gout, Hyperuricemia, Uric Acid (4 papers), Inflammasome and immune disorders (4 papers), Tryptophan and brain disorders (3 papers), Drug Solubulity and Delivery Systems (3 papers), Advanced Drug Delivery Systems (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Biological Psychiatry (23 citations), Pharmaceutical Science (51 citations), Neurology (50 citations), Pharmacology (46 citations) and Nephrology (37 citations). Abdullah Alattar has collaborated with scholars based in Saudi Arabia, Egypt and Pakistan. Frequent co-authors include Reem Alshaman, Fawad Ali Shah, Shupeng Li, Mohammed M.H. Al-Gayyar, Lina T. Al Kury, Zhen Tan, Sawsan A. Zaitone, Tahir Ali, Arif‐ullah Khan and Ahmed M. Hamdan. Their work appears in journals such as Pharmaceuticals, Pharmaceutics, Redox Report, Neurochemical Research and Archives of Medical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.